======= SUV39H2 =======
== Gene Information ==
* **Official Symbol**: SUV39H2
* **Official Name**: suppressor of variegation 3-9 homolog 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79723|79723]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H5I1|Q9H5I1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SUV39H2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SUV39H2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606503|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 using monomethylated H3 'Lys- 9' as substrate. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin at pericentric and telomere regions. H3 'Lys-9' trimethylation is also required to direct DNA methylation at pericentric repeats. SUV39H1 is targeted to histone H3 via its interaction with RB1 and is involved in many processes, such as cell cycle regulation, transcriptional repression and regulation of telomere length. May participate in regulation of higher-order chromatin organization during spermatogenesis. Recruited by the large PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1, contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation. {ECO:0000269|PubMed:14765126}.
|Pre-SET|
|SET|
|Chromo|
|histone H3-K9 dimethylation|
|histone H3-K9 trimethylation|
|histone methyltransferase activity (H3-K9 specific)|
|S-adenosyl-L-methionine binding|
|peptidyl-lysine dimethylation|
|histone H3-K9 methylation|
|negative regulation of circadian rhythm|
|histone H3-K9 modification|
|peptidyl-lysine trimethylation|
|chromosome, centromeric region|
|histone lysine methylation|
|transcription regulatory region sequence-specific DNA binding|
|peptidyl-lysine methylation|
|histone methylation|
|regulation of circadian rhythm|
|chromatin|
|protein alkylation|
|protein methylation|
|chromatin assembly or disassembly|
|chromatin remodeling|
|cellular response to hypoxia|
|cellular response to decreased oxygen levels|
|cellular response to oxygen levels|
|macromolecule methylation|
|rhythmic process|
|methylation|
|peptidyl-lysine modification|
|response to hypoxia|
|response to decreased oxygen levels|
|histone modification|
|covalent chromatin modification|
|response to oxygen levels|
|chromatin organization|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|peptidyl-amino acid modification|
|chromosome organization|
|response to abiotic stimulus|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|cell cycle|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|cellular response to stress|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp302|35°C R06 exp302]]|-2.45|
|[[:results:exp115|A-366 10μM R03 exp115]]|-2.22|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.86|
|[[:results:exp493|IL-3 9ng/ml R08 exp493]]|-1.81|
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.8|
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.77|
|[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.78|
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|1.78|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.88|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16286
* **Expression level (log2 read counts)**: 5.96
{{:chemogenomics:nalm6 dist.png?nolink |}}